EUVIMEDEUVIMED entdecken
Klinische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Use of a digital health solution after percutaneous coronary intervention: a randomised controlled trial

Elias Freyr Gudmundsson, Bartosz Dobies, Brynja Laxdal, Inga Valborg Olafsdottir, Ingibjörg Davidsdottir, Heida Birna Bragadottir, Svala Sigurdardottir, Ari Pall Isberg, Andrew Grannell, Berglind Libungan, Brynjolfur A Mogensen, Hulda Halldorsdottir und 5 weitere

Frontiers in Digital Health · 21.07.2026 · 8

DOI: 10.3389/fdgth.2026.1851777 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Frontiers in Digital Health, online erschienen am 21.07.2026. Verfasst von Elias Freyr Gudmundsson und 16 weiteren Autor:innen. Beteiligte Einrichtung: Sidekick Health, Reykjavik, Iceland. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate a multimodal digital health intervention (SK-121) as an adjunct to standard of care (SoC) to reduce the risk of recurrent cardiovascular events in patients following percutaneous coronary intervention (PCI). Methods and results In this single-centre, randomised controlled trial of 200 patients (mean age 64.4 years; 79.5% male) who underwent PCI, patients were randomised 1:1 to receive SoC alone or SoC plus a 48-week gamified digital program focusing on lifestyle modification and remote patient monitoring (RPM). User retention and engagement were high with 84% remaining active at 24 weeks and weekly RPM completion averaging 94%. The primary endpoint was the baseline-adjusted between-group difference in the Second Manifestations of ARTerial disease, version 2 (SMART2) risk score at 6 months. These SMART2 scores did not differ between the intervention and control groups (adjusted mean difference −0.3%; 95% confidence interval −2.4% to 1.9%; P = 0.821). However, the intervention group significantly improved in disease knowledge at 6 and 12 months ( P < 0.001) and medication adherence at 6 months ( P =0.030). Diastolic blood pressure was significantly lower in the intervention group at 12 months (−3.7 mmHg; P = 0.003). In a post hoc exploratory hypothesis-generating subgroup analysis of overweight participants, the intervention significantly reduced SMART2 scores at 12 months compared to controls (−3.7%; P = 0.033).

Conclusion

While the intervention did not reduce the SMART2 risk score in the overall population, it significantly improved disease knowledge, short-term medication adherence, and diastolic blood pressure. The program was well-accepted and may offer prognostic benefits for overweight patients. Clinical Trial Registration https://clinicaltrials.gov/study/NCT05713565 , NCT05713565.

Schlagwörter

Stichwörter der Autor:innen

cardiac rehabilitationcoronary artery diseasedigital healthdigital therapeuticspercutaneous coronary interventionremote patient monitoringsecondary prevention

Autor:innen und Institutionen

  • Sidekick Health, Reykjavik, Iceland.
  • Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
  • Cardiovascular Services, Landspitali University Hospital, Reykjavik, Iceland.
  • School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Center for Mindfulness, Clinical Medicine, Aarhus University, Aarhus, Denmark.

Zitieren

APA

Gudmundsson, E. F., Dobies, B., Laxdal, B., Olafsdottir, I. V., Davidsdottir, I., Bragadottir, H. B., Sigurdardottir, S., Isberg, A. P., Grannell, A., Libungan, B., Mogensen, B. A., Halldorsdottir, H., Gudmundsdottir, M. V., Kaernested, B., Thorgeirsson, T., Oddsson, S. J., & Arnar, D. O. (2026). Use of a digital health solution after percutaneous coronary intervention: a randomised controlled trial. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1851777

Vancouver

Gudmundsson EF, Dobies B, Laxdal B, Olafsdottir IV, Davidsdottir I, Bragadottir HB, et al. Use of a digital health solution after percutaneous coronary intervention: a randomised controlled trial. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1851777

BibTeX
@article{Gudmundsson2026,
  author = {Gudmundsson, Elias Freyr and Dobies, Bartosz and Laxdal, Brynja and Olafsdottir, Inga Valborg and Davidsdottir, Ingibjörg and Bragadottir, Heida Birna and Sigurdardottir, Svala and Isberg, Ari Pall and Grannell, Andrew and Libungan, Berglind and Mogensen, Brynjolfur A and Halldorsdottir, Hulda and Gudmundsdottir, Maria V and Kaernested, Bylgja and Thorgeirsson, Tryggvi and Oddsson, Saemundur Jon and Arnar, David O},
  title = {Use of a digital health solution after percutaneous coronary intervention: a randomised controlled trial},
  journal = {Frontiers in Digital Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/fdgth.2026.1851777}
}
Kostenlos starten →